RA Capital Management

Ra Capital Management as of March 31, 2018

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Wave Life Sciences (WVE) 23.1 $301M 7.5M 40.10
Ascendis Pharma A S (ASND) 21.2 $277M 4.2M 65.40
Avexis 9.7 $127M 1.0M 123.58
Myovant Sciences 4.6 $60M 2.8M 21.27
Sage Therapeutics (SAGE) 4.4 $57M 353k 161.07
Inflarx Nv (IFRX) 3.6 $47M 1.6M 28.84
Zogenix 3.5 $46M 1.1M 40.05
Dicerna Pharmaceuticals 2.9 $38M 3.9M 9.56
Scpharmaceuticals (SCPH) 2.7 $35M 2.9M 12.40
Endocyte 2.7 $35M 3.9M 9.09
Tg Therapeutics (TGTX) 2.7 $35M 2.5M 14.20
Kala Pharmaceuticals 2.6 $34M 2.1M 15.83
BioCryst Pharmaceuticals (BCRX) 2.5 $33M 7.0M 4.77
Ra Pharmaceuticals 1.6 $21M 3.9M 5.31
Solid Biosciences 1.6 $20M 2.7M 7.50
Apellis Pharmaceuticals (APLS) 1.5 $20M 900k 22.11
Clearside Biomedical (CLSD) 1.2 $16M 1.5M 10.73
AVEO Pharmaceuticals 1.1 $15M 5.1M 2.90
Kalvista Pharmaceuticals (KALV) 1.1 $14M 1.4M 9.48
Catalyst Biosciences 1.0 $13M 515k 25.80
Iovance Biotherapeutics (IOVA) 0.8 $11M 659k 16.90
Spero Therapeutics (SPRO) 0.8 $11M 742k 14.25
Biohaven Pharmaceutical Holding 0.7 $9.4M 364k 25.76
Viking Therapeutics (VKTX) 0.7 $8.9M 2.0M 4.37
Sunesis Pharmaceuticals Inc Ne 0.5 $6.7M 2.5M 2.72
Krystal Biotech (KRYS) 0.4 $5.0M 496k 10.09
Glycomimetics (GLYC) 0.3 $4.1M 254k 16.23
Proteon Therapeutics 0.3 $3.3M 1.3M 2.50
G1 Therapeutics 0.1 $1.5M 40k 37.05
Edge Therapeutics 0.0 $337k 286k 1.18
Cti Biopharma 0.0 $222k 57k 3.90